Meeting Coverage:

EURETINA Congress

EURETINA: 2024

The Role of Anti-VEGF Therapy in Diabetic Vitreous Hemorrhage

Show Description +

Dr. Steel discusses the value of using anti-VEGF therapy to manage diabetic vitreous haemorrhage in select patients, and how it can help address hemorrhage post-PPV for PDR.

Posted: 10/01/2024

Up Next

Exploring VEGF-C and -D Inhibition

Timothy L. Jackson, PhD, MB ChB, FRCOphth

The Clinical Benefits of the PDS

Patricia Udaondo, MD

RD Repair: Why Slower Reattachment is Better

Stratos V. Gotzaridis, MBBS, MD

Today's Approaches to Myopic Neovascularization

Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI

Advancing Research Methodology in Retina

Varun Chaudhary, MD, FRCS(C)

The Clinical Challenges of AAV Vectors

Kanmin Xue, PhD, MA, MB, BChir, FRCOphth

The Role of Anti-VEGF Therapy in Diabetic Vitreous Hemorrhage

Dr. Steel discusses the value of using anti-VEGF therapy to manage diabetic vitreous haemorrhage in select patients, and how it can help address hemorrhage post-PPV for PDR.

Posted: 10/01/2024


Please log in to leave a comment.

More From EURETINA: 2024 Coverage